These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 688611)

  • 1. Clinical analysis of tamoxifen, an anti-neoplastic agent, in plasma.
    Mendenhall DW; Kobayashi H; Shih FM; Sternson LA; Higuchi T; Fabian C
    Clin Chem; 1978 Sep; 24(9):1518-24. PubMed ID: 688611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of products formed during UV irradiation of tamoxifen and their use for fluorescence detection in high-performance liquid chromatography.
    Salamoun J; Macka M; Nechvátal M; Matousek M; Knesel L
    J Chromatogr; 1990 Aug; 514(2):179-87. PubMed ID: 2258394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma.
    Golander Y; Sternson LA
    J Chromatogr; 1980 Jan; 181(1):41-9. PubMed ID: 7364914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
    Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
    Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
    Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
    J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization and biological effects of photocyclized products of tamoxifen irradiation.
    Wilson S; Ruenitz PC
    J Pharm Sci; 1993 Jun; 82(6):571-4. PubMed ID: 8331527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of tamoxifen in serum by thin-layer densitometry.
    Adam HK; Gay MA; Moore RH
    J Endocrinol; 1980 Jan; 84(1):35-42. PubMed ID: 7359080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific high-performance liquid chromatographic analysis of tamoxifen and its major metabolites by "on-line" extraction and post-column photochemical reaction.
    Kikuta C; Schmid R
    J Pharm Biomed Anal; 1989; 7(3):329-37. PubMed ID: 2488634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen monitoring studies in breast cancer patients by micellar liquid chromatography.
    Esteve-Romero J; Ochoa-Aranda E; Bose D; Rambla-Alegre M; Peris-Vicente J; Martinavarro-Domínguez A
    Anal Bioanal Chem; 2010 Jun; 397(4):1557-61. PubMed ID: 20422162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.
    Gjerde J; Kisanga ER; Hauglid M; Holm PI; Mellgren G; Lien EA
    J Chromatogr A; 2005 Jul; 1082(1):6-14. PubMed ID: 16038189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
    Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
    Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography.
    Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J
    Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
    Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
    Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
    Beer B; Schubert B; Oberguggenberger A; Meraner V; Hubalek M; Oberacher H
    Anal Bioanal Chem; 2010 Oct; 398(4):1791-800. PubMed ID: 20730580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical methods for determination of tamoxifen and its phase I metabolites: a review.
    Teunissen SF; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    Anal Chim Acta; 2010 Dec; 683(1):21-37. PubMed ID: 21094378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High performance liquid chromatography of tamoxifen and metabolites in plasma and tissues.
    Lim CK; Chow LC; Yuan ZX; Smith LL
    Biomed Chromatogr; 1993; 7(6):311-4. PubMed ID: 8298286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of tamoxifen and an hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometry.
    Daniel CP; Gaskell SJ; Bishop H; Nicholson RI
    J Endocrinol; 1979 Dec; 83(3):401-8. PubMed ID: 536670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
    Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography.
    Lien EA; Ueland PM; Solheim E; Kvinnsland S
    Clin Chem; 1987 Sep; 33(9):1608-14. PubMed ID: 3621560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.